JPS6321672B2 - - Google Patents
Info
- Publication number
- JPS6321672B2 JPS6321672B2 JP13031180A JP13031180A JPS6321672B2 JP S6321672 B2 JPS6321672 B2 JP S6321672B2 JP 13031180 A JP13031180 A JP 13031180A JP 13031180 A JP13031180 A JP 13031180A JP S6321672 B2 JPS6321672 B2 JP S6321672B2
- Authority
- JP
- Japan
- Prior art keywords
- lactone
- ifo
- substance
- above formula
- compound represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000001875 compounds Chemical class 0.000 claims description 8
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 10
- -1 ML-236B lactone Chemical class 0.000 description 9
- 150000002596 lactones Chemical class 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 238000004809 thin layer chromatography Methods 0.000 description 4
- 241000293029 Absidia caerulea Species 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- AJLFOPYRIVGYMJ-INTXDZFKSA-N mevastatin Chemical class C([C@H]1[C@@H](C)C=CC2=CCC[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 AJLFOPYRIVGYMJ-INTXDZFKSA-N 0.000 description 3
- 230000000813 microbial effect Effects 0.000 description 3
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 241000235555 Cunninghamella Species 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 241000813867 Streptomyces roseochromogenus Species 0.000 description 2
- 241000736855 Syncephalastrum racemosum Species 0.000 description 2
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000002207 metabolite Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000741 silica gel Substances 0.000 description 2
- 229910002027 silica gel Inorganic materials 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 1
- 241000235389 Absidia Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241001290628 Cunninghamella echinulata Species 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 235000002233 Penicillium roqueforti Nutrition 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 241000736854 Syncephalastrum Species 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- RGJOEKWQDUBAIZ-UHFFFAOYSA-N coenzime A Natural products OC1C(OP(O)(O)=O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 RGJOEKWQDUBAIZ-UHFFFAOYSA-N 0.000 description 1
- 239000005516 coenzyme A Substances 0.000 description 1
- 229940093530 coenzyme a Drugs 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- KDTSHFARGAKYJN-UHFFFAOYSA-N dephosphocoenzyme A Natural products OC1C(O)C(COP(O)(=O)OP(O)(=O)OCC(C)(C)C(O)C(=O)NCCC(=O)NCCS)OC1N1C2=NC=NC(N)=C2N=C1 KDTSHFARGAKYJN-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- RPACBEVZENYWOL-XFULWGLBSA-M sodium;(2r)-2-[6-(4-chlorophenoxy)hexyl]oxirane-2-carboxylate Chemical compound [Na+].C=1C=C(Cl)C=CC=1OCCCCCC[C@]1(C(=O)[O-])CO1 RPACBEVZENYWOL-XFULWGLBSA-M 0.000 description 1
- 239000008399 tap water Substances 0.000 description 1
- 235000020679 tap water Nutrition 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pyrane Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (22)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13031180A JPS5767575A (en) | 1980-09-19 | 1980-09-19 | Ml-236b derivative |
| DK247081A DK149080C (da) | 1980-06-06 | 1981-06-04 | Fremgangsmaade til fremstilling af derivater af ml-236b-carboxylsyre |
| MX819478U MX7065E (es) | 1980-06-06 | 1981-06-04 | Un procedimiento microbiologico para preparar derivados de ml-236b |
| DE19813122499 DE3122499A1 (de) | 1980-06-06 | 1981-06-05 | Neue derivate von ml-236b, verfahren zu ihrer herstellung und diese derivate enthaltende arzneimittelzubereitungen |
| US06/270,846 US4346227A (en) | 1980-06-06 | 1981-06-05 | ML-236B Derivatives and their preparation |
| IE1257/81A IE51270B1 (en) | 1980-06-06 | 1981-06-05 | Ml-236b derivatives and their preparation |
| IT67777/81A IT1144598B (it) | 1980-06-06 | 1981-06-05 | Composti farmaceutici atti ad inibire la biosintesi del colesterolo e procedimento per la loro preparazione |
| FR8111190A FR2483912B1 (fr) | 1980-06-06 | 1981-06-05 | Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique |
| AU71376/81A AU549988B2 (en) | 1980-06-06 | 1981-06-05 | Hydroxy esters |
| NL8102737A NL191738C (nl) | 1980-06-06 | 1981-06-05 | ML-236B-derivaten, werkwijze voor hun bereiding en farmaceutische preparaten, die deze derivaten bevatten. |
| CH3722/81A CH655090A5 (de) | 1980-06-06 | 1981-06-05 | Hexahydronaphthalinderivate und ihre herstellung. |
| FI811762A FI71168C (fi) | 1980-06-06 | 1981-06-05 | Foerfarande foer framstaellning av ml-236b-derivat vilka anvaends som laekemedel |
| ES502827A ES502827A0 (es) | 1980-06-06 | 1981-06-05 | Procedimiento de preparar acidos hidroxicarboxilicos y sus derivados. |
| SE8103560A SE453389B (sv) | 1980-06-06 | 1981-06-05 | Hydroxikarboxylsyror, ringslutna laktoner, salter och estrar derav samt forfarande for framstellning av nemnda foreningar |
| CA000379232A CA1150170A (en) | 1980-06-06 | 1981-06-08 | Ml-236b derivatives and their preparation |
| GB8117450A GB2077264B (en) | 1980-06-06 | 1981-06-08 | Ml-236b derivatives and their preparation |
| BE0/205046A BE889150A (fr) | 1980-06-06 | 1981-06-09 | Derives hydroxycarboxyles du compose ml-236b, leur procede de preparation et leur application therapeutique |
| AT0256781A AT374495B (de) | 1980-06-06 | 1981-06-09 | Verfahren zur herstellung neuer derivate der verbindung ml-236b |
| US06/351,974 US4410629A (en) | 1980-06-06 | 1982-02-24 | ML-236B Derivatives and their preparation |
| US06/351,975 US4448979A (en) | 1980-06-06 | 1982-02-24 | ML-236B Derivatives |
| MX9203563A MX9203563A (es) | 1980-06-06 | 1992-06-26 | Derivados de ml-236b y su preparacion. |
| NL960028C NL960028I2 (nl) | 1980-06-06 | 1996-11-18 | ML-236B-derivaten, werkwijze voor hun bereiding enfarmaceutische preparaten, die deze derivaten bevatten. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP13031180A JPS5767575A (en) | 1980-09-19 | 1980-09-19 | Ml-236b derivative |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS5767575A JPS5767575A (en) | 1982-04-24 |
| JPS6321672B2 true JPS6321672B2 (sh) | 1988-05-09 |
Family
ID=15031282
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP13031180A Granted JPS5767575A (en) | 1980-06-06 | 1980-09-19 | Ml-236b derivative |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS5767575A (sh) |
-
1980
- 1980-09-19 JP JP13031180A patent/JPS5767575A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS5767575A (en) | 1982-04-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4448979A (en) | ML-236B Derivatives | |
| Patel et al. | Enantioselective microbial reduction of 3, 5-dioxo-6-(benzyloxy) hexanoic acid, ethyl ester | |
| JPH0371419B2 (sh) | ||
| KR880002483B1 (ko) | 3-히드록시-ml-236b 유도체의 제조방법 | |
| US5491077A (en) | Microbial method | |
| JPH023623A (ja) | 抗高コレステロール血症剤 | |
| JPS6321672B2 (sh) | ||
| FI75186C (fi) | Foerfarande foer framstaellning av ml-236b-derivat. | |
| US3773622A (en) | Method for preparing 2-substituted-4-hydroxy-cyclopentane-1,3-diones | |
| JPH0354103B2 (sh) | ||
| JPS6254476B2 (sh) | ||
| US6451587B1 (en) | Microbial asymmetric reduction of 2-chloro-1-[-6-(2,5-dimethyl-pyrrol-1-yl)-pyridin-3-yl]-ethanone | |
| JPS6348858B2 (sh) | ||
| JPH0355471B2 (sh) | ||
| US4931399A (en) | Process for preparing optically-active glycerol ketal derivatives | |
| JPS61265097A (ja) | 発酵法によるメナキノン−４の製造法 | |
| JPS6319155B2 (sh) | ||
| USRE29163E (en) | 1,2,3,4,10,19-Hexanor-9-oxo-5,9-seco-25D-spirostan-5-oic acid | |
| JPH0333698B2 (sh) | ||
| JPH0482135B2 (sh) | ||
| US3634461A (en) | Spirostan derivative | |
| JPH0367075B2 (sh) | ||
| JPS6328595B2 (sh) | ||
| JPH0538283A (ja) | 新規微生物 | |
| KR840001055B1 (ko) | Ml-236b 유도체의 제조방법 |